-+ 0.00%
-+ 0.00%
-+ 0.00%

This Biotech Stock Sinks Below $1 After Key Eye Drug Fails and Staff Is Slashed. Why There's Still Hope.

Barron‘s·10/19/2026 12:19:00

Please log in to view news